| Product |
Injection Technology
|
|---|---|
| Description of Project |
This contract was awarded to expand the production of the low dead-space (LDS) safety syringes and needles. |
| Unique Impact |
LDS syringes maximize dose efficiency and allow for additional vaccinations to be obtained from vials. The utilization of LDS syringes will allow access to 20 percent more COVID-19 vaccine doses compared to non-LDS syringes. |
| Base Award Amount |
$27,365,232.00
|
| Category |
Therapeutics Supplies and Raw Materials
|